Replies to post #6582 on AEterna Zentaris Inc. (AEZS)

[alexander77]

It is a possibility indeed,because the DSMB evaluation comes earlier as planned. IMO having the potential to become the first FDA approved treatment for endometrial cancer and earlier evaluation, the chances for advising immediate FDA approval rise from 5% to 25%.